TEAM

Educational qualifications

• School of Medicine, National Yang-Ming University, Taipei, Taiwan (1997-2004)

Experience

1. 2010.7~ Attending staff, Division of Pediatric Hematology-Oncology, MacKay Children’s&MacKayMemorial Hospital, Taipei, Taiwan
2. 2017.7~ Principal Investigator of Liver Tumor, Taiwan Pediatric Oncology Group
3. 2016.6~ Adjunct lecturer, MacKay Junior College of Medicine, Nursing andManagement, Taipei, Taiwan
4. 2017.8~ Adjunct lecturer, Department of Medicine, MacKay Medical College, New Taipei City, Taiwan
5. 2019.1~2019.4 Visiting clinical observer, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA
6. 2019.5~2019.6 Visiting clinical observer, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
7. 2023.7~2023.8 Visiting clinical observer, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
8. 2009.7~2010.6 Attending staff, Division of Pediatric Emergency, MacKay Memorial Hospital, Taipei, Taiwan
9. 2007.7~2009.6 Fellow, Division of Pediatric Hematology-Oncology, MacKay Memorial Hospital, Taipei, Taiwan
10. 2004.7~2007.6 Resident, Department of Pediatrics, MacKay Memorial Hospital, Taipei, Taiwan
11. MEMBERSHIP IN SCIENTIFIC SOCIETIES
12. Pediatric Association of Taiwan
13. Hematology Society of Taiwan
14. Taiwan Pediatric Oncology Group
15. Pediatric Emergency Medicine of Taiwan Pediatric Association
16. Taiwan Society of Blood and Marrow Transplantation
17. Taiwan Society of Thrombosis and Hemostasis
18. International Society of Pediatric Oncology (SIOP)
19. The European Association for Haemophilia and Allied Disorders (EAHAD)

Areas of expertise

1. Pediatric hematology-oncology
2. Acute leukemia
3. Hepatoblastoma
4. Coagulopathy

Professional writings

• (2021~2024)
• Hou JY, Yeh TC, Huang TH, Sheu JC, Liu HC. A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma: A single institution experience. PediatrNeonatol. 2021 Apr 27;S1875-9572(21)00061-9. doi: 10.1016/j.pedneo.2021.03.018.
• Ho WL, Hung GY, Yen HJ, Yang YL, Chang HH, Lu MY, Lin KH, Chen JS, Cheng CN, Hung IJ, Yang CP, Chen SH, Liu HC, Yeh TC, Hou JY, et al. Characteristics and outcomes of second cancers in patients with childhood cancer: A report from the Taiwan Pediatric Oncology Group.J Formos Med Assoc. 2022 Jan;121(1 Pt 2):350-359. doi: 10.1016/j.jfma.2021.05.012. Epub 2021 Jun 18.
• Andrés-Jensen L, Attarbaschi A, Bardi E, Barzilai-Birenboim S, Bhojwani D, Hagleitner MM, Halsey C, Harila-Saari A, van Litsenburg RRL, Hudson MM, Jeha S, Kato M, Kremer L, Mlynarski W, Möricke A, Pieters R, Piette C, Raetz E, Ronceray L, Toro C, Grazia Valsecchi M, Vrooman LM, Weinreb S, Winick N, Schmiegelow K; Ponte di Legno Severe Toxicity Working Group. (Ponte di Legno Severe Toxicity Working Group: Andishe Attarbaschi, Madeline R Adams, Liv Andres-Jensen, Edit Bardi, Shlomit Barzilai-Birenboim, Katja Baust, Deepa Bhojwani, Tineke Boesten, Gabriele Calaminus, Rachel Conyers, Anne-Sophie Darlington, Maëlle de Ville, Gabriele Escherich, Melanie Hagleitner, Christina Halsey, Arja Harila-Saari, Jen-Yin Hou, et al. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. Lancet Haematol. 2021 Jul;8(7):e513-e523. doi: 10.1016/S2352-3026(21)00136-8.
• Yeh TC, Hou JY, Huang TH, Lu CH, Sun FJ, Huang HM, Liu HC. Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia. Sci Rep. 2021 Oct 27;11(1):21142. doi: 10.1038/s41598-021-00725-5.
• Singkham N, Punyawudho B, Yu MS, Cheng SN, Chen SH, Chang H, Chen CC, Hsiao CC, Hou JY, et al.Influence of blood group and von Willebrand factor on population pharmacokinetics and dose individualization of recombinant factor VIII in Taiwanese patients with haemophilia A. Haemophilia. 2022 Mar;28(2):230-238. doi: 10.1111/hae.14493. Epub 2022 Jan 20.
• Wang CH, Cheng KH, Hou JY.Sonographic diagnosis of intramural duodenal hematoma.PediatrNeonatol. 2022 Aug 11:S1875-9572(22)00176-0. doi: 10.1016/j.pedneo.2022.07.003.
• Huang TH, Hung GY, Weng TF, Wang FM, Lee CY, Lin DT, Chen BW, Lin KH, Wu KH, Liu HC, Chen JS, Jou ST, Hou JY,et al. Surgical treatment confers prognostic significance in pediatric malignant mediastinal germ cell tumors.Cancer. 2022 Dec 1;128(23):4139-4149. doi: 10.1002/cncr.34494.
• Liu YC, Yeh TC, Wu PS, Sheu JC, Lee HC, Yeung CY, Jiang CB, Liu HC, Hou JY, Chan WT. Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.Medicine (Baltimore). 2022 Nov 25;101(47):e31752. doi: 10.1097/MD.0000000000031752.
• Liang ML, Yeh TC, Huang MH, Wu PS, Wu SP, Huang CC, Yen TY, Ting WH, Hou JY, et al. Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural Metastases. Diagnostics (Basel). 2023 Mar 24;13(7):1232. doi: 10.3390/diagnostics13071232.
• Lew CZ, Liu HC, Hou JY, Huang TH, Yeh TC. Pediatric Extracranial Germ Cell Tumors: Review of Clinics and Perspectives in Application of Autologous Stem Cell Transplantation. Cancers (Basel). 2023 Mar 27;15(7):1998. doi: 10.3390/cancers15071998.
• Lin YC, Liu HC, Hou JY, Shih BF, Yeh TC. Pediatric Cardiac Lymphoblastic Lymphoma: A Case Report and Review of the Literature. J PediatrHematol Oncol. 2023 Jul 1;45(5):281-284. doi: 10.1097/MPH.0000000000002676. Epub 2023 Apr 17.
• Hou JY, Hsieh PY, Lei R, Chen CM, Cheng M, Chen YC. A Prospective, Observational, Multi-Center Study of Rurioctocog Alfa Pegol Pharmacokinetic-Guided Prophylaxis Using Mypkfit in Severe Hemophilia a Patients in Taiwan (ATTRACT-HA Study): An Interim Analysis. Blood (2023) 142 (Supplement 1): 5484.
• Liu HC, Huang YJ, Jaing TH, Wu KH, Chen SH, Wang SC, Yeh TC, Hsiao CC, Chang TK, Yen HJ, Huang FL, Lin PC,Hou JY, et al. Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1plus and Day 15 MRD positivity. Br J Haematol. 2024 Apr;204(4):1344-1353. doi: 10.1111/bjh.19338. Epub 2024 Mar 13.
• Lu YA, Liu HC,Hou JY, Chiu NC, Huang TH, Yeh TC. The clinical impact of primary granulocyte-colony stimulating factor prophylaxis in children with acute lymphoblastic leukemia who underwent induction chemotherapy. J MicrobiolImmunol Infect. 2024 Aug 20:S1684-1182(24)00148-8. doi: 10.1016/j.jmii.2024.08.004.